Nanostring: Bringing the next generation Biomarkers to the clinic
Current research tools to predict patient response to immunotherapy are hampered by low information content, limited reproducibility, high input requirements, cumbersome protocols, or slow turn-around time. Dr Cesano will describe multiplexed assay designed to triage patients to novel and existing immunotherapies and combinations based on the parallel assessment and integration, in one single assay and sample, of multiple mechanisms of immune evasion.
In addition, Dr Cesano will present NanoString’s Digital Spatial Profiling technology (DSP). The DSP technology performs a whole slide imaging, allowing in one single reaction, to capture tissue morphology and to select regions of interests for highly multiplexed, spatially resolved profiling experiments with up to 800 barcoded reagents.
Chief Medical Officer
Nanostring Technologies HQ